chr13-110641600-G-T

Variant summary

Our verdict is Benign. The variant received -9 ACMG points: 0P and 9B. BP4_StrongBP6BS2

The NM_024537.4(CARS2):​c.1632C>A​(p.Ser544Arg) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00045 in 1,613,552 control chromosomes in the GnomAD database, including 2 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. S544G) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.0027 ( 2 hom., cov: 33)
Exomes 𝑓: 0.00022 ( 0 hom. )

Consequence

CARS2
NM_024537.4 missense

Scores

2
15

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:2B:4

Conservation

PhyloP100: 0.211

Publications

3 publications found
Variant links:
Genes affected
CARS2 (HGNC:25695): (cysteinyl-tRNA synthetase 2, mitochondrial) This gene encodes a putative member of the class I family of aminoacyl-tRNA synthetases. These enzymes play a critical role in protein biosynthesis by charging tRNAs with their cognate amino acids. This protein is encoded by the nuclear genome but is likely to be imported to the mitochondrion where it is thought to catalyze the ligation of cysteine to tRNA molecules. A splice-site mutation in this gene has been associated with a novel progressive myoclonic epilepsy disease with similar symptoms to MERRF syndrome. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jun 2017]
CARS2 Gene-Disease associations (from GenCC):
  • combined oxidative phosphorylation defect type 27
    Inheritance: AR Classification: STRONG, MODERATE, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Orphanet, Laboratory for Molecular Medicine, G2P
  • mitochondrial disease
    Inheritance: AR Classification: MODERATE Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -9 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0034243166).
BP6
Variant 13-110641600-G-T is Benign according to our data. Variant chr13-110641600-G-T is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 475624.
BS2
High Homozygotes in GnomAd4 at 2 AR gene

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_024537.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CARS2
NM_024537.4
MANE Select
c.1632C>Ap.Ser544Arg
missense
Exon 15 of 15NP_078813.1
CARS2
NM_001352252.2
c.846C>Ap.Ser282Arg
missense
Exon 16 of 16NP_001339181.1
CARS2
NR_147941.1
n.1716C>A
non_coding_transcript_exon
Exon 17 of 17

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CARS2
ENST00000257347.9
TSL:1 MANE Select
c.1632C>Ap.Ser544Arg
missense
Exon 15 of 15ENSP00000257347.4
CARS2
ENST00000939453.1
c.1776C>Ap.Ser592Arg
missense
Exon 15 of 15ENSP00000609512.1
CARS2
ENST00000890914.1
c.1626C>Ap.Ser542Arg
missense
Exon 15 of 15ENSP00000560973.1

Frequencies

GnomAD3 genomes
AF:
0.00264
AC:
402
AN:
152200
Hom.:
2
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.00914
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00118
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000441
Gnomad OTH
AF:
0.000956
GnomAD2 exomes
AF:
0.000648
AC:
163
AN:
251442
AF XY:
0.000500
show subpopulations
Gnomad AFR exome
AF:
0.00874
Gnomad AMR exome
AF:
0.000434
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000176
Gnomad OTH exome
AF:
0.000652
GnomAD4 exome
AF:
0.000220
AC:
321
AN:
1461234
Hom.:
0
Cov.:
30
AF XY:
0.000190
AC XY:
138
AN XY:
726974
show subpopulations
African (AFR)
AF:
0.00741
AC:
248
AN:
33464
American (AMR)
AF:
0.000537
AC:
24
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26136
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39700
South Asian (SAS)
AF:
0.00
AC:
0
AN:
86246
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53350
Middle Eastern (MID)
AF:
0.000349
AC:
2
AN:
5726
European-Non Finnish (NFE)
AF:
0.00000540
AC:
6
AN:
1111528
Other (OTH)
AF:
0.000679
AC:
41
AN:
60360
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.454
Heterozygous variant carriers
0
17
34
52
69
86
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00266
AC:
405
AN:
152318
Hom.:
2
Cov.:
33
AF XY:
0.00231
AC XY:
172
AN XY:
74486
show subpopulations
African (AFR)
AF:
0.00919
AC:
382
AN:
41570
American (AMR)
AF:
0.00118
AC:
18
AN:
15306
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5180
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4826
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10614
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.0000441
AC:
3
AN:
68032
Other (OTH)
AF:
0.000946
AC:
2
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
21
42
62
83
104
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000973
Hom.:
3
Bravo
AF:
0.00296
ESP6500AA
AF:
0.00726
AC:
32
ESP6500EA
AF:
0.00
AC:
0
ExAC
AF:
0.000741
AC:
90

ClinVar

ClinVar submissions as Germline

Significance:Conflicting classifications of pathogenicity
Revision:criteria provided, conflicting classifications
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
1
1
Combined oxidative phosphorylation defect type 27 (2)
-
-
1
CARS2-related disorder (1)
-
-
1
Inborn genetic diseases (1)
-
-
1
not provided (1)
-
1
-
not specified (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Uncertain
0.40
BayesDel_addAF
Benign
-0.52
T
BayesDel_noAF
Benign
-0.52
CADD
Benign
13
DANN
Benign
0.96
DEOGEN2
Benign
0.13
T
Eigen
Benign
-0.69
Eigen_PC
Benign
-0.74
FATHMM_MKL
Benign
0.64
D
LIST_S2
Benign
0.52
T
MetaRNN
Benign
0.0034
T
MetaSVM
Benign
-1.0
T
MutationAssessor
Uncertain
2.2
M
PhyloP100
0.21
PrimateAI
Benign
0.36
T
PROVEAN
Benign
-1.6
N
REVEL
Benign
0.035
Sift
Benign
0.37
T
Sift4G
Benign
0.13
T
Polyphen
0.10
B
Vest4
0.22
MutPred
0.24
Gain of MoRF binding (P = 0.0167)
MVP
0.39
MPC
0.26
ClinPred
0.0084
T
GERP RS
2.9
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Varity_R
0.12
gMVP
0.23
Mutation Taster
=93/7
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs141184379; hg19: chr13-111293947; API